<DOC>
	<DOC>NCT00207129</DOC>
	<brief_summary>The purpose of this study is to test how BMS-247550 (ixabepilone) affects the removal of capecitabine from the body and how capecitabine affects the removal of BMS-247550 from the body.</brief_summary>
	<brief_title>Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Recovery from surgery or radiation therapy Measurable or nonmeasurable disease Available for followup Neuropathy Uncontrolled pulmonary or cardiovascular disease Known history of HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>